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Background
Previous studies evaluating cardiac effects of chemother-
apy have focussed on the left ventricle (LV) and largely
been retrospective. Although right ventricle (RV) systolic
dysfunction is an adverse prognostic marker in cardio-
myopathy states, the RV effects of chemotherapy are not
well defined.
Methods
Thirty six breast cancer patients undergoing chemother-
apy (26 anthracyline, 10 tranztumab) underwent serial
CMR imaging (for LV and RV volumes/ejection frac-
tion) and echocardiography for tricuspid annular systolic
plane excursion (TAPSE) at baseline, 1, 3 and 12
months. RV impairment following chemotherapy was
defined as an reduction of CMR RVEF below normal
range (defined as 50%)1 and/or an absolute reduction of
RVEF of at least 5% from baseline.
Results
Significant changes in CMR volumes and systolic func-
tion were observed in both the ventricles (table).
Although LV function decreased, EF remained above
the lower limit of normal (defined as 57%1) in all
patients. RV function changes were of greater magni-
tude. 23% of patients had significant RV impairment at
3 months and 81% had RV impairment evident at 12
months (as defined above). TAPSE decreased from 23±3
to 21.1±3; p<0.001 at 3 months. Patients that received
anthracyclines were more likely to have significant RV
impairment at 12 months, p value <0.005.
Conclusions
RV functional changes can be detected both early and
late following current chemotherapy regimes using
CMR and modern echocardiographic techniques.
Although anthracyclines likely causes biventricular dys-
function, in our study they were more likely to cause
persistent RV impairment at 12 months. These findings
support routine surveillance of RV function in contem-
porary breast cancer chemotherapy.
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Table 1 Functional changes following chemotherapy
LVEDVI LVESVI LVEF LVMM RVEDVI RVESVI RVEF
Baseline (n=33) 63±12 17±6 72±6 48±9 66±14 25±8 63±8
1 month (n=33) 64±11 20±6** 69±6** 50±9 69±15 27±8* 60±6*
3 mths (n=33) 65±12 21±7** 68±6** 48±9 67±13 28±7** 58±6**
12 mths (n=21) 73±14** 26±10** 65±6** 40±6 71±11* 35±7** 51±9*
*p <0.05 **p<0.001
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